The expression mechanism of programmed cell death 1 ligand 1 and its role in immunomodulatory ability of mesenchymal stem cells

被引:0
|
作者
Chen, Zhuo [1 ,2 ]
Yao, Meng-Wei [1 ]
Ao, Xiang [3 ]
Gong, Qing-Jia [2 ]
Yang, Yi [4 ]
Liu, Jin-Xia [5 ]
Lian, Qi-Zhou [6 ]
Xu, Xiang [1 ]
Zuo, Ling-Jing [7 ]
机构
[1] Army Med Univ, Daping Hosp, Dept Stem Cell & Regenerat Med, State Key Lab Trauma Burn & Combined Injury, Chongqing 400042, Peoples R China
[2] Army Med Univ, Coll Basic Med Sci, Chongqing 400038, Peoples R China
[3] Army Med Univ, Hosp PLA 953, Dept Orthoped, Shigatse Branch,Xinqiao Hosp, Shigatse 857000, Tibet Autonomou, Peoples R China
[4] Army Med Univ, Daping Hosp, Dept Rheumatol & Immunol, Chongqing 400042, Peoples R China
[5] Chongqing Peoples Hosp, Dept Obstet & Gynecol, Chongqing 401121, Peoples R China
[6] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Hong Kong, Peoples R China
[7] Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Affiliated Hosp, Dept Nucl Med, Kunming 650034, Peoples R China
基金
中国国家自然科学基金;
关键词
PD-L1; MSCs; Immunomodulation; REGULATE PD-L1 EXPRESSION; PD-LL EXPRESSION; UP-REGULATION; IFN-GAMMA; STROMAL CELLS; TNF-ALPHA; IMMUNOSUPPRESSIVE PROPERTIES; MEDIATED IMMUNOSUPPRESSION; SIGNALING PATHWAYS; ANTITUMOR IMMUNITY;
D O I
10.1016/j.cjtee.2023.11.003
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Programmed cell death 1 ligand 1 (PD-L1) is an important immunosuppressive molecule, which inhibits the function of T cells and other immune cells by binding to the receptor programmed cell death-1. The PD-L1 expression disorder plays an important role in the occurrence, development, and treatment of sepsis or other inflammatory diseases, and has become an important target for the treatment of these diseases. Mesenchymal stem cells (MSCs) are a kind of pluripotent stem cells with multiple differentiation potential. In recent years, MSCs have been found to have a strong immunosuppressive ability and are used to treat various inflammatory insults caused by hyperimmune diseases. Moreover, PD-L1 is deeply involved in the immunosuppressive events of MSCs and plays an important role in the treatment of various diseases. In this review, we will summarize the main regulatory mechanism of PD-L1 expression, and discuss various biological functions of PD-L1 in the immune regulation of MSCs. (c) 2024 Production and hosting by Elsevier B.V. on behalf of Chinese Medical Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:1 / 10
页数:10
相关论文
共 50 条
  • [1] The expression mechanism of programmed cell death 1 ligand 1 and its role in immunomodulatory ability of mesenchymal stem cells
    Chen Zhuo
    Yao Meng-Wei
    Ao Xiang
    Gong Qing-Jia
    Yang Yi
    Liu Jin-Xia
    Lian Qi-Zhou
    Xu Xiang
    Zuo Ling-Jing
    [J]. 中华创伤杂志(英文版), 2024, 27 (01)
  • [2] Prognostic effect of programmed cell death ligand 1/programmed cell death 1 expression in cancer stem cells of human oral squamous cell carcinoma
    Todoroki, Keita
    Abe, Yushi
    Matsuo, Katsuhisa
    Nomura, Hidetoshi
    Kawahara, Akihiko
    Nakamura, Yoshiaki
    Nakamura, Moriyoshi
    Seki, Naoko
    Kusukawa, Jingo
    [J]. ONCOLOGY LETTERS, 2024, 27 (02)
  • [3] Expression of programmed cell death ligand 1 and programmed cell death 1 in cutaneous warts
    Yu, Wesley Y.
    Berger, Timothy G.
    North, Jeffrey P.
    Laszik, Zoltan
    Cohen, Jarish N.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (05) : 1127 - 1133
  • [4] Programmed Cell Death Ligand 1 Expression in Osteosarcoma
    Shen, Jacson K.
    Cote, Gregory M.
    Choy, Edwin
    Yang, Pei
    Harmon, David
    Schwab, Joseph
    Nielsen, G. Petur
    Chebib, Ivan
    Ferrone, Soldano
    Wang, Xinhui
    Wang, Yangyang
    Mankin, Henry
    Hornicek, Francis J.
    Duan, Zhenfeng
    [J]. CANCER IMMUNOLOGY RESEARCH, 2014, 2 (07) : 690 - 698
  • [5] Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma
    Kim, Ryul
    Keam, Bhumsuk
    Kwon, Dohee
    Ock, Chan-Young
    Kim, Miso
    Kim, Tae Min
    Kim, Hak Jae
    Jeon, Yoon Kyung
    Park, In Kyu
    Kang, Chang Hyun
    Kim, Dong-Wan
    Kim, Young Tae
    Heo, Dae Seog
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (37) : 8389 - 8397
  • [6] Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma
    Ryul Kim
    Bhumsuk Keam
    Dohee Kwon
    Chan-Young Ock
    Miso Kim
    Tae Min Kim
    Hak Jae Kim
    Yoon Kyung Jeon
    In Kyu Park
    Chang Hyun Kang
    Dong-Wan Kim
    Young Tae Kim
    Dae Seog Heo
    [J]. World Journal of Gastroenterology, 2016, 22 (37) : 8389 - 8397
  • [7] Exploring the role of programmed cell death protein 1 and its ligand 1 in eye diseases
    Wang, Xiu
    Wu, Mianmian
    Cao, Yunshan
    Zhang, Zhi
    Guo, Fang
    Li, Xiaorong
    Zhang, Yan
    [J]. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2019, 56 (01) : 18 - 32
  • [8] Prognostic implication of programmed cell death 1 protein and programmed cell death 1 ligand 1 expression in endometrial cancer
    Kim, J.
    Choi, J. H.
    Kong, J.
    Yang, W.
    Cho, H.
    Chay, D. B.
    Kim, J. H.
    [J]. GYNECOLOGIC ONCOLOGY, 2018, 149 : 47 - 47
  • [9] Association of disease activity with programmed cell death 1 and its ligand programmed cell death ligand 1 expressions in lupus patients
    Eissa, Eman
    Kandil, Rania
    El-Ghobashy, Nehal
    Abdelfattah, Walaa
    Hammouda, Zainab
    Gadelsayed, Sara Medhat
    Bayoumi, Faten
    [J]. INDIAN JOURNAL OF RHEUMATOLOGY, 2022, 17 (04) : 347 - 352
  • [10] Programmed cell death 1 ligand 1 signals in cancer cells
    Kornepati, Anand V. R.
    Vadlamudi, Ratna K.
    Curie, TylerJ
    [J]. NATURE REVIEWS CANCER, 2022, 22 (03) : 174 - 189